Tokyo Tape
Sign in
← Yamashita Health Care Holdings

Quarterly report · Q2

9265.TEDINET S100SKGJ
Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥28.9bn2023-06-01 → 2023-11-30Cons.Net sales
Revenue¥58.2bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥27.7bn2022-06-01 → 2022-11-30Cons.Net sales
Operating income¥618m2023-06-01 → 2023-11-30Cons.Operating income
Operating income¥598m2022-06-01 → 2022-11-30Cons.Operating income
Ordinary income¥645m2023-06-01 → 2023-11-30Cons.Ordinary income
Ordinary income¥1.2bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥624m2022-06-01 → 2022-11-30Cons.Ordinary income
Profit before tax¥700m2023-06-01 → 2023-11-30Cons.Income before income taxes
Profit before tax¥20m2022-06-01 → 2022-11-30Cons.Income before income taxes
Net income (owners)¥480m2023-06-01 → 2023-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥201m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income¥477m2023-06-01 → 2023-11-30Cons.Profit loss
Net income−¥204m2022-06-01 → 2022-11-30Cons.Profit loss
Total assets¥24.8bnat 2023-11-30Cons.Assets
Total assets¥24.6bnat 2023-05-31Cons.Assets
Total assets¥22.9bnat 2022-11-30Cons.Total assets (5-year summary)
Total liabilities¥16.5bnat 2023-11-30Cons.Liabilities
Total liabilities¥16.6bnat 2023-05-31Cons.Liabilities
Net assets / equity¥8.3bnat 2023-11-30Cons.Net assets
Net assets / equity¥7.9bnat 2023-05-31Cons.Net assets
Net assets / equity¥7.6bnat 2022-11-30Cons.Net assets (5-year summary)
Cash and deposits¥5.0bnat 2023-11-30Cons.Cash and deposits
Cash and deposits¥5.8bnat 2023-05-31Cons.Cash and deposits
Cash & equivalents¥5.0bnat 2023-11-30Cons.Cash and cash equivalents
Cash & equivalents¥5.8bnat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2022-05-31dCons.Cash and cash equivalents
Operating cash flow−¥544m2023-06-01 → 2023-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.2bn2022-06-01 → 2023-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.9bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥154m2023-06-01 → 2023-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥107m2022-06-01 → 2023-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥88m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥123m2023-06-01 → 2023-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥209m2022-06-01 → 2023-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥209m2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥188.052023-06-01 → 2023-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥124.522023-09-01 → 2023-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥85.832022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-78.982022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-143.682022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio33.5%at 2023-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio32.2%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.2%at 2022-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-06-01 → 2023-11-30¥0
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2023-11-30¥0
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2023-11-30−¥494m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2023-06-01 → 2023-11-30¥146m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2023-06-01 → 2023-11-30¥146m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2023-06-01 → 2023-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2023-06-01 → 2023-11-30¥6m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2023-06-01 → 2023-11-30¥28.7bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2023-06-01 → 2023-11-30¥28.7bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2023-06-01 → 2023-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2023-06-01 → 2023-11-30¥1.1bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2023-06-01 → 2023-11-30¥36m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2023-06-01 → 2023-11-30¥36m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2023-06-01 → 2023-11-30¥2m
—segment totalrevenue2023-06-01 → 2023-11-30¥28.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥28.9bn
—segment totalrevenue intersegment2023-06-01 → 2023-11-30¥0
—segment totalsegment profit2023-06-01 → 2023-11-30¥1.1bn
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥447m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥140m
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥0
jpcrp040300-q2r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥3m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2022-11-30¥27.5bn
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥11m
jpcrp040300-q2r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2022-11-30¥1.0bn
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2022-11-30¥33m
jpcrp040300-q2r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2022-11-30¥0
—segment totalrevenue2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥27.7bn
—segment totalrevenue intersegment2022-06-01 → 2022-11-30¥11m
—segment totalsegment profit2022-06-01 → 2022-11-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 490
ItemContextValueUnit
Non operating incomePrior1YTDDuration34000000JPY
Non operating incomeCurrentYTDDuration40000000JPY
Interest expenses noePrior1YTDDuration1000000JPY
Interest expenses noeCurrentYTDDuration0JPY
Foreign exchange losses noePrior1YTDDuration2000000JPY
Foreign exchange losses noeCurrentYTDDuration4000000JPY
Loss on sales of notes payable noePrior1YTDDuration4000000JPY
Loss on sales of notes payable noeCurrentYTDDuration3000000JPY
Compensation expenses noePrior1YTDDuration－JPY
Compensation expenses noeCurrentYTDDuration3000000JPY
Equity in losses of affiliates noePrior1YTDDuration－JPY
Equity in losses of affiliates noeCurrentYTDDuration0JPY
Other noePrior1YTDDuration0JPY
Other noeCurrentYTDDuration1000000JPY
Non operating expensesPrior1YTDDuration7000000JPY
Non operating expensesCurrentYTDDuration14000000JPY
Ordinary incomePrior1YTDDuration624000000JPY
Ordinary incomeCurrentYTDDuration645000000JPY
Reversal of allowance for doubtful accounts eiPrior1YTDDuration－JPY
Reversal of allowance for doubtful accounts eiCurrentYTDDuration54000000JPY
Receipts from contingent consideration eiPrior1YTDDuration6000000JPY
Receipts from contingent consideration eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration6000000JPY
Extraordinary incomeCurrentYTDDuration54000000JPY
Provision of allowance for doubtful accounts elPrior1YTDDuration611000000JPY
Provision of allowance for doubtful accounts elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration611000000JPY
Extraordinary lossCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration20000000JPY
Income before income taxesCurrentYTDDuration700000000JPY
Income taxes currentPrior1YTDDuration53000000JPY
Income taxes currentCurrentYTDDuration48000000JPY
Income taxes deferredPrior1YTDDuration170000000JPY
Income taxes deferredCurrentYTDDuration175000000JPY
Income taxesPrior1YTDDuration224000000JPY
Income taxesCurrentYTDDuration223000000JPY
Profit lossPrior1YTDDuration-204000000JPY
Profit lossCurrentYTDDuration477000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-2000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-201000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration480000000JPY
Profit lossPrior1YTDDuration-204000000JPY
Profit lossCurrentYTDDuration477000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration2000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration54000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration10000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration7000000JPY
Other comprehensive incomePrior1YTDDuration13000000JPY
Other comprehensive incomeCurrentYTDDuration62000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-05-31pass
balance sheet identityconsolidated 2023-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2023-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2023-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2023-06-01/2023-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2023-06-01/2023-11-30pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2023-11-30pass